Ionis Pharmaceuticals Inc... (IONS)
NASDAQ: IONS
· Real-Time Price · USD
43.76
0.91 (2.12%)
At close: Aug 15, 2025, 3:59 PM
43.97
0.49%
After-hours: Aug 15, 2025, 07:55 PM EDT
Ionis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 452.05M | 131.61M | 226.58M | 134M | 225.25M | 119.5M | 324.5M | 144M | 188M | 131M | 152M | 159.77M | 133.79M | 141.92M | 440M | 133.09M | 125.75M | 111.61M |
Cost of Revenue | 4.15M | 1.46M | 3.83M | 1.07M | 9.74M | 7.8M | 3.06M | 2M | 3M | 1M | 4M | 1.51M | 4.75M | 4.17M | 2M | 3.08M | 2.96M | 2.58M |
Gross Profit | 447.9M | 130.15M | 222.75M | 132.93M | 215.51M | 111.69M | 321.44M | 142M | 185M | 130M | 148M | 158.25M | 129.05M | 137.75M | 438M | 130.01M | 122.79M | 109.03M |
Operating Income | 139.82M | -146.86M | -110.82M | -148.66M | -66.09M | -149.51M | -6.12M | -143M | -91M | -114M | -208M | -59.14M | -85.51M | -57.48M | 221M | -85.85M | -72.97M | -91.97M |
Interest Income | n/a | n/a | -9K | 2.23M | n/a | 49K | 3.28M | 23.93M | n/a | 18.63M | 11.88M | 7.52M | 30K | n/a | 149K | 40K | 377K | 14K |
Pretax Income | 123.53M | -146.82M | -107.04M | -144.1M | -66.2M | -142.73M | -2.77M | -141M | -77M | -113M | -44M | -46.71M | -102.88M | -64.07M | 225M | -83.77M | -80.55M | -89.74M |
Net Income | 123.55M | -146.94M | -104.35M | -140.48M | -66.27M | -142.8M | -9.26M | -147M | -85M | -124M | -52M | -46.99M | -105.14M | -65.17M | 225M | -82.47M | -80.88M | -89.87M |
Selling & General & Admin | 90.6M | 76.25M | 88.1M | 61.6M | 59.53M | 46.99M | 71M | 70M | 46M | 46M | 47.9M | 34.4M | 33.8M | 34.1M | 38M | 30.1M | 45.1M | 57.1M |
Research & Development | 217.46M | 200.76M | 245.49M | 219.76M | 222.06M | 214.22M | 256.56M | 215M | 230M | 198M | 308M | 182.99M | 180.76M | 161.13M | 179M | 184.77M | 139.31M | 139.8M |
Other Expenses | 22K | n/a | -21K | 38K | 610K | 277K | 399K | n/a | n/a | n/a | n/a | n/a | n/a | 187K | n/a | -469K | -189K | 3K |
Operating Expenses | 308.08M | 277.01M | 333.57M | 281.4M | 281.6M | 261.21M | 327.56M | 285M | 276M | 244M | 356M | 217.39M | 214.56M | 195.23M | 217M | 214.87M | 184.41M | 196.9M |
Interest Expense | 21.25M | 22.93M | 22.86M | 21.23M | 22.79M | 20.56M | 20.85M | 21.98M | 19.95M | 17.12M | 1.73M | 2.14M | 800K | 800K | 2.24M | 2.34M | n/a | 1.5M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -5.65M | n/a | n/a | -100K | 484K | n/a | n/a | n/a | n/a | -600K | n/a | n/a | n/a |
Cost & Expenses | 312.23M | 278.47M | 337.44M | 282.47M | 291.34M | 269.01M | 330.62M | 287M | 279M | 245M | 360M | 218.91M | 219.3M | 199.4M | 219M | 217.95M | 187.36M | 199.48M |
Income Tax Expense | -20K | 116K | -3M | -3.62M | 64K | 75K | 6.5M | 6M | 8M | 11M | 8M | 283K | 2.26M | 1.09M | 303K | -1.31M | 327K | 130K |
Shares Outstanding (Basic) | 159.14M | 158.74M | 158M | 148.59M | 145.96M | 145.54M | 144M | 143.32M | 143.1M | 142.74M | 142M | 141.95M | 141.79M | 141.6M | 141M | 141.14M | 140.96M | 140.77M |
Shares Outstanding (Diluted) | 182.33M | 158.74M | 158M | 148.59M | 145.96M | 145.54M | 144M | 143.32M | 143.1M | 142.74M | 142M | 141.95M | 141.79M | 141.6M | 160M | 141.14M | 140.96M | 140.77M |
EPS (Basic) | 0.78 | -0.93 | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 | -1.03 | -0.59 | -0.87 | -0.37 | -0.33 | -0.74 | -0.46 | 1.59 | -0.58 | -0.57 | -0.64 |
EPS (Diluted) | 0.70 | -0.93 | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 | -1.03 | -0.59 | -0.87 | -0.37 | -0.33 | -0.74 | -0.46 | 1.41 | -0.58 | -0.57 | -0.64 |
EBITDA | 150.23M | -143.89M | -78.87M | -115.91M | -37.84M | -114.97M | 25.17M | -113.23M | -51.81M | -90.21M | -35.24M | -39.48M | -95.66M | -57.5M | 232.53M | -78.73M | -73.18M | -82.47M |
EBIT | 144.78M | -150.93M | -84.14M | -121.41M | -43.41M | -122.17M | 18.08M | -120.43M | -57.5M | -97.12M | -43.93M | -45.91M | -100.75M | -61.95M | 222.1M | -82.87M | -78.19M | -88.24M |
Depreciation & Amortization | 5.45M | 7.04M | 5.27M | 5.49M | 5.58M | 5.65M | 5.61M | 5.59M | 5.69M | 5.61M | 7.03M | 5.09M | 5.09M | 4.89M | 4.98M | 4.71M | 5.01M | 4.86M |